Exploring CSF biomarkers in amyotrophic lateral sclerosis: Highlighting thesignificance of TDP-43

Written By Yiran Gan
Exploring CSF Biomarkers in Amyotrophic Lateral Sclerosis: Highlighting the Significance of TDP-43 - Kuo et al. 2025

Exploring CSF Biomarkers in Amyotrophic Lateral Sclerosis: Highlighting the Significance of TDP-43

Publication Date: 2025.05.15

Authors: Yih-Chih Kuo, Chih-Chao Yang, Li-Kai Tsai

Journal: Journal of the Neurological Sciences, Volume 472, 123479, May 15, 2025

© 2025 Kuo, Yang and Tsai

Journal of the Neurological Sciences - Elsevier

Yiran Gan
Previous

Plasma extracellular vesicle neurofilament lightchain as the biomarkers of the progressionof Parkinson’s disease
Next

Assay of Neurodegenerative Biomarkers in Human Plasma of Patients with Parkinson’s Disease